Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Mary Ann Lockett"'
Autor:
Mary L. Vest, Courtney Coke, Gordon W. Philpott, Leanne McBurney, Joseph R. Simpson, Robert R. Kuske, Karen J. Halverson, Mary Ann Lockett, Delia M. Garcia, Carol Rush, Robert J. Myerson, Carlos A. Perez, George Tucker, Jerome F. Levy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::274500fceca771396ee982fef1eeddc4
https://doi.org/10.1159/000422084
https://doi.org/10.1159/000422084
Publikováno v:
The Cancer Journal. 10:349-356
The purpose of this study was to evaluate the impact of elapsed treatment time in external-beam radiation therapy for localized prostate carcinoma.The medical records of 1083 patients with localized prostate carcinoma treated between 1970 and Decembe
Autor:
Christopher H. Crane, Marc E. Delclos, Nora A. Janjan, Thomas E. Read, Ira J. Kodner, James W. Fleshman, Elisa H. Birnbaum, A. Chandra, Howard D. Thames, Barry W. Feig, John M. Skibber, Joel Picus, Edward H. Lin, T. Phan, Mary Ann Lockett, Anurag K. Singh, Robert J. Myerson
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 57:84-89
To compare the outcome from preoperative chemoradiation (CXRT) and from radiation therapy (RT) in the treatment of rectal cancer in two large, single-institutional experiences.Between 1978 and 1995, 403 patients with localized, nonmetastatic, clinica
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 56:342-347
Purpose To review the outcome for 56 Stage I non–small-cell lung cancer treated definitively with three-dimensional conformal radiotherapy (3D-CRT) and to investigate the value of elective nodal irradiation in this patient population. Methods and m
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 49:1287-1296
Purpose: To compare postirradiation biochemical disease-free survival using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus or elevation of postirradiation prostate-specific antigen (PSA) level beyond 1 ng/mL as an endpoi
Autor:
James W. Fleshman, Elisa H. Birnbaum, Joel Picus, Robert D. Fry, Robert J. Myerson, Ira J. Kodner, Domenico Genovesi, Mary Ann Lockett, Thomas E. Read, Bruce J. Walz, Jondavid Menteer
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 43:537-543
Randomized Swedish studies demonstrate the efficacy of a 5-fraction course of preoperative radiotherapy for rectal carcinoma. The present study evaluates the results in a single U.S. institution over a 20-year period with a similar regimen.During the
Autor:
Perry W. Grigsby, M. Garipagaoglu, Mary Ann Lockett, Andrew E. Galakatos, Carlos A. Perez, K.S.Clifford Chao, David G. Mutch
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 42:335-344
Purpose: This report reviews the increasing role of radiation therapy in the management of patients with histologically confirmed vulvar carcinoma, based on a retrospective analysis of 68 patients with primary disease (2 in situ and 66 invasive) and
Autor:
Andrew G. Antell, William L. Straube, Alyson Buckner, Mary Ann Lockett, Bahman Emami, Ernesto P. Molmenti, Henry K. Lee, Carlos A. Perez, Ganeshan Ramachandran, Robert J. Myerson
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 40:365-375
To correlate patient-, tumor-, and treatment-related factors with subsequent local tumor control.From 1977 to 1990, 196 subcutaneous/superficial lesions (179 measurable, 17 microscopic) in 151 patients with recurrent breast carcinoma of the chest wal
Autor:
Todd H. Wasserman, Beverly J. Kobeissi, Mary Ann Lockett, Jeff M. Michalski, Stacey Ballard, Carlos A. Perez, Robert E. Drzymala
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 39:875-883
PURPOSE In a health care environment strongly concerned with cost containment, cost-benefit studies of new technology must include analyses of loco-regional tumor control, morbidity, impact on quality of life, and financial considerations. METHODS AN
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 36:573-584
Purpose: A great deal of controversy exists regarding the potential benefit of pelvic lymph node irradiation compared with treatment to the prostate only in patients with localized prostate cancer. Despite numerous reports, including a randomized stu